A clinical trial of tang shen ning for treatment of diabetic nephropathy.
This paper reports the clinical trial of Tang Shen Ning ([symbol: see text], TSN) for treating diabetic nephropathy (incipient and clinical, as divided by Mogensen). The results showed that the total effective rate in treatment group (TSN + western medicine) was 90.0%, and that in the control group (simply with western medicine), 56.7%. TSN plays important roles in decreasing proteinuria and improving renal functions.
Gao
Y
Y
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine and Pharmacy.
Lü
R
R
Wang
X
X
Geng
J
J
Ren
K
K
Wang
Y
Y
Zhao
J
J
Yu
X
X
Chen
D
D
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019413:Qi; D016710:Yin Deficiency / Q000188:drug therapy*
D000959:Antihypertensive Agents; D004365:Drugs, Chinese Herbal; D002216:Captopril